Anthony Taparo is Chief Growth Officer at Surgery Partners, Inc. (SGRY). They have made 11 open-market trades across 1 company since 2021, most recently 2024-03-12.
CIK 0001735245
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGRY | 102,321 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2024-03-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGRY | SELL | 2024-03-11 | 2024-03-13 | $29.72 | $43K | +0.3% | -7.6% | -12.7% |
| SGRY | SELL | 2024-03-05 | 2024-03-06 | $30.70 | $41K | -10.8% | -11.1% | -16.4% |
| SGRY | SELL | 2024-02-13 | 2024-02-14 | $33.40 | $37K | -6.4% | -16.3% | -20.7% |
| SGRY | SELL | 2023-03-13 | 2023-03-15 | $30.95 | $299K | +5.2% | +21.7% | +29.0% |
| SGRY | SELL | 2023-02-27 | 2023-03-01 | $33.52 | $441K | -10.1% | +2.9% | +8.9% |
| SGRY | SELL | 2023-02-13 | 2023-02-15 | $33.91 | $37K | -4.3% | -10.6% | +2.1% |
| SGRY | SELL | 2022-03-24 | 2022-03-28 | $53.50 | $268K | -2.8% | -4.5% | -44.5% |
| SGRY | SELL | 2022-03-15 | 2022-03-17 | $49.59 | $905K | +6.0% | +4.0% | -45.3% |
| SGRY | SELL | 2022-03-11 | 2022-03-14 | $55.00 | $36K | +5.6% | +8.3% | -39.0% |
| SGRY | SELL | 2022-02-28 | 2022-03-02 | $52.28 | $591K | -10.5% | -1.6% | -30.4% |
| SGRY | SELL | 2021-05-10 | 2021-05-10 | $50.55 | $6.4M | +9.9% | +30.0% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.